Paper commissioned for the EFA Global Monitoring Report 2010, Reaching the marginalized
This toolkit is designed as a resource for CBM that can be used in a variety of ways: to support staff induction, team meetings, refresher days and training workshops. It can also be used as a tool for personal reflection and self-study. Tips for those intending to use it as a training resource are ...shaded differently.
more
Guidelines for Prevention and Reponse
Traumata werden definiert als Ereignisse von außergewöhnlicher Bedrohung, die nahezu bei jedem tiefgreifende Verzweiflung auslösen würde. Die „klassische“ Posttraumatische Belastungsstörung (PTBS) ist gekennzeichnet durch Intrusionen, Vermeidung und Hyperausal. Die komplexe Posttraumatische... Belastungsstörung (KPTBS) wird als eigenständige Diagnose in das ICD-11 aufgenommen und tritt als Folge von sich wiederholenden oder langandauernden traumatischen Ereignissen auf. Die KPTBS ist neben den Symptomen der PTBS durch Affektregulationsstörungen, negative Selbstwahrnehmung und Beziehungsstörungen gekennzeichnet. Aktuelle empirische Studien lieferten Hinweise für die Validität dieser Diagnose. Die Exposition in sensu mit dem traumatischen Ereignis steht im Mittelpunkt der als erfolgreich evaluierten Psychotherapien der PTBS und der KPTBS. Zur differenziellen Wirkung einzelner traumafokussierter Verfahren bei KPTBS können jedoch noch keine eindeutigen Empfehlungen ausgesprochen werden.
more
In support of the African decade of disabled persons | 1st January 199 - 31st of December 2009
Oxford Policy Management (OPM) - APW with UNAIDS (thru TSF)
This month 600 people reached Greece, mostly to Lesvos island. UNHCR with IOM and UNICEF welcomed the latest relocations of 49 unaccompanied children from Greece to Portugal and Finland and called for more. The need for such solutions is high as only one in four has a place in a shelter. The prematu...re end of accommodation assistance may lead recognized refugees to become homeless.
more
This study addresses part of the Terms of Reference for a scoping report ‘An analysis of approaches to laboratory capacity strengthening for drug resistant infections in low and middle income countries’. It has been produced as a separate report because it is also very relevant for a second stud...y ‘Supporting Surveillance Capacity for Antimicrobial Resistance: Regional Networks and Educational Resources’. This study compares antimicrobial surveillance systems in three low and middle income countries in order to describe the components of these systems and to understand which surveillance models are best suited to particular contexts. Ghana, Nigeria and Nepal were selected as study countries because they cover different continents and include one ‘fragile’ context (Nigeria). Brief information from Malawi is also included.
more
The guide seeks to address questions about how we can face local communication challenges presented by the pandemic, and how communicators respond effectively to the situation through supporting our communities to cope and to protect themselves. This guide aims to provide insights for a wide range o...f local communicators on the community level. It covers the need for knowing and communicating the facts coronavirus, understanding the pandemics’ timeline and accompanying communication phases, and accessing resources and materials; it also contains information about what needs communicating and key messages, and consideration about communication design options for appropriate communication routes and methods and essential communication planning
more
This note provides a few ideas to a challenging problem of reaching survivors who cannot easily access phone-based GBV support. It is very much a living document given the evolving nature of the pandemic and may be adapted as more evidence, insights and lessons become available. It is intended to sp...ark conversation in the hope that additional contributions and innovations from others will result.
more
In its report from 2014, the Working Group outlines the various factors influencing vaccine acceptance or refusal, and what can be done to create social norms around vaccine acceptance and to encourage the general public regarding the necessity of vaccination.
The results of the SHINE trial have been published in the NEJM today. SHINE looked at whether treatment for children with minimal TB could be reduced from 6 months to 4 months. It found that the four month treatment was as good as the standard six months treatment for children with minimal TB
This report presents the types of cluster munitions being used in the international armed conflict in Ukraine in 2022 and the civilian casualties immediately suffered and civilian objects damaged.
Since the first edition of the CDAC snapshot of communication, community engagement and accountability (CCEA) across the Ukraine response was published in May 2022, a conscious effort has been made by international, national and local responders to ramp up CCEA action. Progress has been made in esta...blishing coordination mechanisms and launching activities, particularly around accountability to affected people (AAP). As CCEA work continues to scale up on the ground, a greater focus and more effort are still needed on community-facing information and two-way communication; this should be accorded a higher priority than at present.
more
Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses to address the many outstanding resea...rch questions. This systematic review aims to describe the characteristics and treatment practices of clinical studies in CD and assess the breadth and availability of research data for the potential establishment of a data-sharing platform.
more
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de...velopment of next-generation vaccines against COVID-19 variants and we are planning studies to answer critical scientific questions related to the durability of immunity, effectiveness of mixed-vaccine regimens, and vaccine effectiveness in vulnerable populations such as pregnant women. We are also bringing forward our plans to develop vaccines that could protect against multiple COVID-19 variants and other coronavirus specie
more